These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 6195199)
21. Effect of dietary treatment on the renal tubular function in a patient with hereditary tyrosinemia. Suzuki Y; Konda M; Imai I; Imamura H; Shimao S; Okaka T Int J Pediatr Nephrol; 1987; 8(3):171-6. PubMed ID: 3429140 [TBL] [Abstract][Full Text] [Related]
22. [A case of tyrosinemia type II with convulsion and EEG abnormality]. Kato M; Suzuki N; Koeda T No To Hattatsu; 1993 Nov; 25(6):558-62. PubMed ID: 8260211 [TBL] [Abstract][Full Text] [Related]
23. Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers. Burns RP Am J Ophthalmol; 1972 Mar; 73(3):400-2. PubMed ID: 4401188 [No Abstract] [Full Text] [Related]
25. The Richner-Hanhart syndrome: report of a case with associated tyrosinemia. Bienfang DC; Kuwabara T; Pueschel SM Arch Ophthalmol; 1976 Jul; 94(7):1133-7. PubMed ID: 180943 [TBL] [Abstract][Full Text] [Related]
26. Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart syndrome). Al-Ratrout JT; Al-Muzian M; Al-Nazer M; Ansari NA Ann Saudi Med; 2005; 25(5):422-4. PubMed ID: 16270769 [No Abstract] [Full Text] [Related]
27. Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia. Fellman JH; Vanbellinghen PJ; Jones RT; Koler RD Biochemistry; 1969 Feb; 8(2):615-22. PubMed ID: 4389443 [No Abstract] [Full Text] [Related]
28. [Type II oculo-cutaneous tyrosinosis]. Gounod N; Ogier H; Dufier JL; Larrègue M; Saudubray JM; de Prost Y Ann Dermatol Venereol; 1984; 111(8):697-8. PubMed ID: 6152137 [No Abstract] [Full Text] [Related]
29. Tyrosinemia II: report of an incomplete case and studies on the hyperkeratotic stratum corneum. Saijo S; Kudoh K; Kuramoto Y; Horii I; Tagami H Dermatologica; 1991; 182(3):168-71. PubMed ID: 1831773 [TBL] [Abstract][Full Text] [Related]
35. Studies on the metabolism of the phenolic acids in hereditary tyrosinemia by a gas-liquid chromatographic method. Gentz J; Lindblad B; Lindstedt S; Zetterström R J Lab Clin Med; 1969 Aug; 74(2):185-202. PubMed ID: 5799507 [No Abstract] [Full Text] [Related]
36. Tyrosinaemia in circumscribed palmo-plantar keratoderma-follow-up of a previously reported case. Callan NJ Australas J Dermatol; 1976 Dec; 17(3):126. PubMed ID: 139885 [No Abstract] [Full Text] [Related]
37. [Type II oculo-cutaneous tyrosinosis or Richner-Hanhart syndrome--apropos of a case]. Foels MO; Dufier JL; Renard G; Gounod N; D'Hermies F; Pouliquen Y Bull Soc Ophtalmol Fr; 1989 Jan; 89(1):21-4. PubMed ID: 2574638 [No Abstract] [Full Text] [Related]
38. Dietary management of oculocutaneous tyrosinemia in an 11-year-old child. Ney D; Bay C; Schneider JA; Kelts D; Nyhan WL Am J Dis Child; 1983 Oct; 137(10):995-1000. PubMed ID: 6225330 [TBL] [Abstract][Full Text] [Related]
39. Gas-liquid chromatography of phenylalanine metabolites in urine and sera of hyperphenylalaninemic and phenylketonuric patients. Kitagawa T Clin Chem; 1974 Dec; 20(12):1543-7. PubMed ID: 4430132 [No Abstract] [Full Text] [Related]
40. [The metabolic basis of the hyperphenylalaninemias and tyrosinemia]. Shintaku H Nihon Rinsho; 1992 Jul; 50(7):1542-7. PubMed ID: 1357201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]